The peptide does not rely on a single receptor or mechanism but instead orchestrates healing through several complementary routes simultaneously
Rats treated with BPC-157 showed significantly accelerated healing of incisional wounds, with treated animals demonstrating better collagen organization, increased tensile strength of healing tissue, and faster closure times compared to control groups
Moreover, we have found that EqASC EMS treated with the 50 nM exogenous SHBG have presented dense, small globules and twisting-like mitochondrial morphotypes that additionally confirm enhanced mitophagy and improved bioenergetic status

These represent reported experience rather than validated clinical practice: Typical Reported Range Starting dose: 510 mg orally per day Common maintenance: 1020 mg per day Exploratory high-end: 2030 mg per day in some reports Most reports cluster around 1015 mg daily as a "standard" dose Dosing frequency varies: some take it once daily, others split into two doses Timeline to Perceived Effects Anecdotal reports suggest a variable timeline: Some users report subjective effects (improved mood, mental clarity) within 37 days Others report delayed effects after 24 weeks Some users report no discernible effects even at higher doses Effects are highly individual and may depend on baseline cognition, genetics, health status, and other factors Why 10mg Is a Conservative Starting Point The 10 mg tablet format has become the de facto standard in community use